Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
Clinical trial NCT05776979 · RECRUITING
Trial details
- NCT number
- NCT05776979
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-17
- Primary completion
- 2027-12-31
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.